Moreover, LCN2 promotes cell migration and invasion of prostate cancer by inducing epithelial-to-mesenchymal transition via the extracellular signal-regulated kinase (ERK)/SLUG pathway. The gene discussed is LCN2; the disease is prostate carcinoma.